Ignota Labs applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues, rescuing promising but failing drugs and bringing new life to abandoned projects and new hope to patients.

Generate Biomedicines is a new kind of therapeutics company—existing at the intersection of machine learning, biological engineering, and medicine—pioneering generative biology to create breakthrough medicines.

UnNatural Products creates entirely new drugs by engineering synthetic molecules to mimic nature’s macrocycles. Their platform produces passively permeable, macrocyclic peptides that access and address traditionally undruggable targets.

Atomic AI is developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.